Recent Quotes (30 days)

You have no recent quotes
chg | %

Cellmid Limited  

(Public, ASX:CDY)   Watch this stock  
Find more results for CDY
0.505
+0.005 (1.00%)
Delayed:   12:55PM GMT+11
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.50 - 0.50
52 week 0.02 - 0.80
Open 0.50
Vol / Avg. 2,974.00/30,751.00
Mkt cap 28.74M
P/E     -
Div/yield     -
EPS -0.09
Shares 53.42M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -116.40% -94.65%
Operating margin -107.38% -104.16%
EBITD margin - -100.85%
Return on average assets -63.48% -56.27%
Return on average equity -102.97% -98.41%
CDP Score - -

Address

City Freehold Se 1802 L 18, 15 Castlereagh St
SYDNEY, NSW 2000
Australia
+61-2-92216830 (Phone)
+61-2-92218535 (Fax)

Website links

Description

Cellmid Limited develops and markets therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The Company operates in two segments: research and development of diagnostics and therapeutics, and research, development and marketing of hair growth products. It develops and commercializes diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine (Midkine Businesses, Lyramid and Kinera), and the development and sale of over-the-counter (OTC) treatments to alleviate excessive and abnormal hair loss, and re-establish the natural hair growth cycle (Consumer Health Business). Its products include Midkine ELISA kit; Advangen International hair loss products, and Evolis products, which are a range of hair growth products. The Company, through its subsidiaries, develops and sells treatments for various forms of hair loss (alopecia).

Officers and directors

Maria Julianna Halasz Chief Executive Officer, Managing Director, Executive Director
Raymond Ting Financial Controller, Company Secretary
David William King Independent Non-Executive Chairman of the Board
Martin George Cross Non-Executive Director
Bruce Gordon Non-Executive Director
Edward Fintan Walton Non-Executive Director